ACE2 and infection: In the context of COVID-19 and the development of fibrotic lung disease, higher ACE2 levels induced by smoke may facilitate viral entry/infection, leading to ACE2 downregulation and an imbalance in RAS; pathologically, this is typified by inflammation and pneumonia followed by aberrant repair and extensive fibrosis.